Treatment of Balanitis Xerotica Obliterans with Topical Floucinolone Acetonide Cream

Abstract

This is a case control study which included (40) patients with Balanitis Xerotica Obliterans (B.X.O.), from the 3rd of Feb. 2009 to the 3rd of Sept. 2011,(25)patients (Group A) were treated with topical Floucinolone Acetonide (0.025%) cream , the other (15) patients (Group B) did not receive any treatment. All patients were followed up for (30) days, in (Group A) 18(72%) patients showed an improvement in their symptoms and 20(80%) patients had a higher urine flow rates than before treatment, but those patients in (Group B) showed no improvement or became worse.